Common Contracts
211 similar null contracts by Deciphera Pharmaceuticals, Inc., Enliven Therapeutics, Inc., IDEAYA Biosciences, Inc., others
OPEN MARKET SALE AGREEMENTSMAstria Therapeutics, Inc. • March 4th, 2024 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMMerus N.V. • February 28th, 2024 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMSutro Biopharma, Inc. • February 9th, 2024 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALES AGREEMENTSMIDEAYA Biosciences, Inc. • January 19th, 2024 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMProkidney Corp. • January 19th, 2024 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSMLexicon Pharmaceuticals, Inc. • December 29th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMOmniAb, Inc. • December 8th, 2023 • Services-commercial physical & biological research • New York
OPEN MARKET SALE AGREEMENTSMFate Therapeutics Inc • November 8th, 2023 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSMESSA Pharma Inc. • November 6th, 2023 • Pharmaceutical preparations • New York
ESSA Pharma Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), the Company’s common shares, without par value (the “Common Shares”), having an aggregate offering price of up to US$50,000,000 on the terms set forth in this agreement (this “Agreement”).
OPEN MARKET SALE AGREEMENTSMPrime Medicine, Inc. • November 3rd, 2023 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSMDisc Medicine, Inc. • October 10th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMThird Harmonic Bio, Inc. • October 2nd, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMDeciphera Pharmaceuticals, Inc. • August 9th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALES AGREEMENT1Recursion Pharmaceuticals, Inc. • August 8th, 2023 • Biological products, (no disgnostic substances) • New York
Recursion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s Class A common stock, par value $0.00001 per share (the “Class A Common Shares”), having an aggregate offering price of up to $300,000,000 on the terms set forth in this sales agreement (this “Agreement”). The Class A Common Shares and the shares of the Company’s Class B common stock, par value $0.00001 per share, are referred to herein as the “Common Stock.”
OPEN MARKET SALE AGREEMENTSMBluebird Bio, Inc. • August 8th, 2023 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALES AGREEMENTSMIDEAYA Biosciences, Inc. • June 30th, 2023 • Pharmaceutical preparations • New York
Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(a)(6) OPEN MARKET SALE AGREEMENTSMEnliven Therapeutics, Inc. • June 26th, 2023 • Pharmaceutical preparations • New York
Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(a)(6) OPEN MARKET SALE AGREEMENTSMEnliven Therapeutics, Inc. • June 23rd, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMVeru Inc. • May 12th, 2023 • Pharmaceutical preparations • New York
AMENDED AND RESTATED OPEN MARKET SALE AGREEMENTSMCarisma Therapeutics Inc. • May 12th, 2023 • Pharmaceutical preparations • New York
Carisma Therapeutics Inc. (formerly Sesen Bio, Inc.), a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.001 per share (the “Common Shares”), under one or more registration statements on Form S-3 filed with the Commission (as defined below) on the terms set forth in this agreement (this “Agreement”). This Agreement hereby amends and restates in its entirety that certain Open Market Sale AgreementSM dated November 29, 2019, by and between the Company and the Agent, as amended by Amendment No. 1, dated October 30, 2020, Amendment No. 2, dated February 17, 2021, and Amendment No. 3, dated June 1, 2021 (the “Original Agreement”), which Original Agreement shall have no further force or effect.
OPEN MARKET SALE AGREEMENTSMDeciphera Pharmaceuticals, Inc. • May 3rd, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMCorvus Pharmaceuticals, Inc. • March 29th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMVigil Neuroscience, Inc. • March 21st, 2023 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSMAkero Therapeutics, Inc. • March 17th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMPrelude Therapeutics Inc • March 15th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMKaryopharm Therapeutics Inc. • February 17th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMKineta, Inc./De • February 10th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMVectivBio Holding AG • January 27th, 2023 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSMArdelyx, Inc. • January 19th, 2023 • Pharmaceutical preparations • New York
KALA PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) OPEN MARKET SALE AGREEMENTSMKala Pharmaceuticals, Inc. • January 19th, 2023 • Pharmaceutical preparations • New York
OPEN MARKET SALE AGREEMENTSMBioAtla, Inc. • January 6th, 2023 • Biological products, (no disgnostic substances) • New York
AT-THE-MARKET EQUITY OFFERING SALES AGREEMENTVor Biopharma Inc. • December 23rd, 2022 • Biological products, (no disgnostic substances) • New York
OPEN MARKET SALE AGREEMENTSM374Water Inc. • December 22nd, 2022 • Motors & generators • New York
OPEN MARKET SALE AGREEMENTSMWejo Group LTD • December 21st, 2022 • Services-computer processing & data preparation • New York
OPEN MARKET SALE AGREEMENTSMVentyx Biosciences, Inc. • December 20th, 2022 • Pharmaceutical preparations • New York
